Upgrade to SI Premium - Free Trial

AcelRx Pharma (ACRX) Resubmits NDA for DSUVIA

May 9, 2018 7:26 AM
AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), (AcelRx or the Company), a specialty pharmaceutical company focused on innovative therapies for use ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Corporate News FDA Management Comments

Next Articles